Whether Array is worth $11 billion for Pfizer is dependent on whether both Braftovi and Mektovi are needed in colorectal cancer. (Array BioPharma) One key incent...

Amarin will double its sales force for fish-oil derivative Vascepa on the back of a record six months of sales. (Pixabay) Amarin has been teasing big plans ...

Gilead said Tuesday it plans to submit its experimental arthritis treatment filgotinib for U.S. approval this year, a speedier-than-expected timeline that could shor...

Women with ovarian cancer who have undergone four or more rounds of chemotherapy typically haven't had much hope that another treatment option will lengthen their li...

Strategic collaboration leverages CluePoints’ Central Statistical Monitoring (CSM) technology to enhance data quality and reduce operational costs Wayne, PA, June...

Boehringer Ingelheim and Eli Lilly's Jardiance is chasing the FDA's blessing in chronic heart failure. (Boehringer Ingelheim) When Boehringer Ingelheim and Eli L...

Minerva Neurosciences is developing seltorexant with Janssen as an add-on treatment for major depressive disorder and insomnia disorder. (alex-mit/iStock/Getty Imag...